Results 241 to 250 of about 21,386 (303)

TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease? [PDF]

Biomedicines
Takai K.
europepmc   +1 more source

Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients. [PDF]

Front Immunol
Feng A, Gonzalez MV, Kalaycioglu M, Yin X, Mumau M, Shyamsundar S, Bustamante MS, Chang SE, Dhingra S, Dodig-Crnkovic T, Schwenk JM, Garg T, Yoshizaki K, van Rhee F, Fajgenbaum DC, Utz PJ.   +15 more
europepmc   +1 more source

TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease

, 2017
Gordan Srkalović, Inga Marijanović, Maya Blanka Srkalovic, David C. Fajgenbaum   +3 more
openalex   +2 more sources

Co-occurrence of Neuromyelitis Optica Spectrum Disorder and Idiopathic Multicentric Castleman Disease Successfully Treated with Tocilizumab. [PDF]

Intern Med
Tsuzuki Wada T, Yokota K, Okada M, Ichimura T, Ueno T, Okumura N, Osawa I, Inoue K, Akiyama Y, Nakazato Y, Sasaki A, Yamamoto T, Mimura T.   +12 more
europepmc   +1 more source

Dysregulated lymphocyte localization in idiopathic multicentric Castleman disease

Melanie Mumau, Michael Gonzalez, Katherine S. Forsyth, M. Betina Pampena, Abiola Irvine, Criswell Lavery, Joseph Zinski, Ira D. Miller, Thomas Barnett Dubensky, Derek A. Oldridge, Laura A. Vella, Michael R. Betts, David C. Fajgenbaum   +12 more
openalex   +2 more sources

Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease. [PDF]

Intern Med
Ozaki T, Imada C, Shirakami K, Abe T, Shingai Y, Umeki T, Fukuda A, Ishii K, Shibata H.   +8 more
europepmc   +1 more source

Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease. [PDF]

J Clin Exp Hematop
Nishikori A, Nishimura MF, Tomida S, Chijimatsu R, Ueta H, Lai YC, Kawahara Y, Takeda Y, Ochi S, Haratake T, Ennishi D, Nakamura N, Momose S, Sato Y.   +13 more
europepmc   +1 more source

Disseminated dermatophytosis in a patient with idiopathic multicentric Castleman disease on siltuximab therapy — a case report

Katarzyna Piszczek-Onak, Przemysław Hałubiec, Agnieszka Giza, Paweł Krzyściak, Grzegorz Dyduch, Anna B. Wojas-Pelc, Andrzej K. Jaworek   +6 more
openalex   +2 more sources

Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's Disease. [PDF]

N Engl J Med
Mumau MD, Gonzalez MV, Ma C, Irvine AH, Sarmiento Bustamante M, Shyamsundar S, Chen LYC, Koslicki D, Fajgenbaum DC.   +8 more
europepmc   +1 more source

Successful Treatment of Idiopathic Multicentric Castleman Disease With Rash as the Initial Symptom Using a Rituximab-Based Regimen. [PDF]

J Hematol
Zhu L, Liu Y, Yu F, Yin XJ, Yao QM, Meng HT, You LS, Tong HY.   +7 more
europepmc   +1 more source